Close
Achema middle east
swop processing & packaging

News

EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2

EMA has received an application for conditional marketing authorisation (CMA) for BNT162b2, a COVID?19 mRNA vaccine developed by BioNTech and Pfizer. The assessment of BNT162b2...

Biogen partners with Sage Therapeutics on depression, movement disorder drugs

Biogen entered into an agreement to jointly develop and commercialise Sage Therapeutics' zuranolone for major depressive disorder (MDD) and postpartum depression (PDD), as well as...

AstraZeneca Says Forxiga Approved In Japan For Heart Failure

AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chronic heart failure (HF) who are receiving standard of care. HF is...

Lonza invests to expand manufacturing capabilities at Oregon site

Lonza AG has announced a significant investment to expand its particle engineering and drug product capabilities to meet increased market demand at its Bend, Oregon...

Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing with U.S. FDA for EUA

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the...

Moderna Announces Amendment to Current Supply Agreement with UK Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19

Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a...

Wasdell Group strengthens PPFL business with ISO 13485 for medical devices

The Wasdell Group, a leading outsourcing partner to companies in the pharmaceutical and biotech sector, has  announced that its Dundalk, Ireland facility has been certified...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »